Short answer
Nuvation Bio Inc. (NUVB) filed an 8-K current report with the SEC on May 27, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). 2026 annual meeting achieved quorum with 389,931,796 shares represented, including 83.6% of Class A and 100% of Class B shares.
Nuvation Bio Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- 2026 annual meeting achieved quorum with 389,931,796 shares represented, including 83.6% of Class A and 100% of Class B shares
- Robert B. Bazemore Jr. and Robert Mashal re-elected as Class A directors through the 2029 annual meeting
- Kim Blickenstaff re-elected as Class B director with 1,000,000 votes
- KPMG LLP ratified as independent auditor for fiscal year ending December 31, 2026, with 290,273,104 votes for
- Executive compensation approved advisory basis with 230,050,644 votes for, supporting current pay practices despite 55,602,434 broker non-votes
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Nuvation Bio Inc. 8-K filings
Get the next NUVB 8-K as it lands
Follow NUVB for push alerts, or ask the research agent what this filing means.